HeraMED Limited is a medical data and technology company specializing in the digital transformation of maternity care. The company develops and deploys connected pregnancy monitoring solutions for both home and professional use, with its flagship products including the HeraBEAT fetal heartbeat monitor and the HeraCARE remote maternity care platform. HeraBEAT is a medical-grade, clinically validated device that enables expectant mothers to monitor their baby's heart rate at home, transmitting data via Bluetooth to smartphones for real-time tracking. HeraCARE integrates hardware and software to deliver comprehensive remote monitoring and personalized care plans, supporting improved maternal health outcomes. HeraMED collaborates with leading medical institutions such as the Mayo Clinic and Sheba Medical Center, and its technology is deployed in markets including the United States, Australia, and Israel. The company is focused on leveraging artificial intelligence and machine learning to enhance its monitoring capabilities and expand access to quality prenatal care globally.